Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Continuing Operations (2016 - 2026)

Amphastar Pharmaceuticals has reported Income from Continuing Operations over the past 13 years, most recently at 58416000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 34.67% year-over-year to 58416000.0; the TTM value through Dec 2025 reached 132081000.0, down 20.2%, while the annual FY2025 figure was 132081000.0, 20.2% down from the prior year.
  • Income from Continuing Operations for Q4 2025 was 58416000.0 at Amphastar Pharmaceuticals, up from 17350000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 58416000.0 in Q4 2025 and troughed at 145250000.0 in Q4 2023.
  • A 5-year average of 14387150.0 and a median of 25855000.0 in 2023 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 703.36% in 2021 and later crashed 494.19% in 2022.
  • Year by year, Income from Continuing Operations stood at 23652000.0 in 2021, then crashed by 494.19% to 93234000.0 in 2022, then crashed by 55.79% to 145250000.0 in 2023, then skyrocketed by 129.86% to 43378000.0 in 2024, then skyrocketed by 34.67% to 58416000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for AMPH at 58416000.0 in Q4 2025, 17350000.0 in Q3 2025, and 31030000.0 in Q2 2025.